Proposed rule would implement how civil monetary penalties will be applied to manufacturers that “knowingly and intentionally” deny 340B prices to eligible health care providers.

The ranking member on the Senate Judiciary Committee sends a letter to the University of Alabama Hospital seeking details on how it has changed the admission status and treatment of patients to get 340B drug discounts for patients who would not have been eligible otherwise.

The Health Resources and Services Administration has begun random and targeted audits of health care providers participating in the federal 340B drug discount program to help ensure products are not being diverted for other uses or resulting in manufacturers paying double discounts to Medicaid.